High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI
International Journal of Pediatrics · 2015 · 2015 · 1-7
DOI: 10.1155/2015/397372 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pediatrics, 2015. Verfasst von Sheikh Sohail Ahmed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Section of Pediatric Critical Care, Pediatric Sedation and Cardiovascular Intensive Care Unit, Riley Hospital for Children …. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
To determine the efficacy and safety of high dose dexmedetomidine as a sole sedative agent for MRI. We report our institution’s experience.
Design
A retrospective institutional review of dexmedetomidine usage for pediatric MRI over 5.5 years. Protocol included a dexmedetomidine bolus of 2 μ g/kg intravenously over ten minutes followed by 1 μ g/kg/hr infusion. 544 patients received high dose dexmedetomidine for MRI. A second bolus was used in 103 (18.9%) patients. 117 (21.5%) required additional medications. Efficacy, side effects, and use of additional medicines to complete the MRI were reviewed. Data was analyzed using Student’s t -test, Fisher’s exact test, and Analysis of Variance (ANOVA). Main Results. Dexmedetomidine infusion was associated with bradycardia (3.9%) and hypotension (18.4%). None of the patients required any intervention. Vital signs were not significantly different among the subgroup of patients receiving one or two boluses of dexmedetomidine or additional medications. Procedure time was significantly shorter in the group receiving only one dexmedetomidine bolus and increased with second bolus or additional medications ( P < 0.0001 ). Discharge time was longer for children experiencing bradycardia ( P = 0.0012 ).
Conclusion
High dose Dexmedetomidine was effective in 78.5% of cases; 21.5% of patients required additional medications. Side effects occurred in approximately 25% of cases, resolving spontaneously. Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
Autor:innen und Institutionen
- Department of Pediatrics, Section of Pediatric Critical Care, Pediatric Sedation and Cardiovascular Intensive Care Unit, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, 7…
- Department of Pediatrics, Pediatric Procedural Sedation, Riley Hospital for Children at IU Health North, 11700 N. Meridian Street, Carmel, IN 46032, USA.
- Department of Biostatistics, Indiana University School of Medicine, 410 W. 10th Street, Suite 3000, Indianapolis, IN 46202, USA.
- Department of Pediatrics, Section of Pediatric Critical Care, Riley Hospital for Children at Indiana University Health, Indiana University School of Medicine, 705 Riley Hospital Drive RI 4909 4B, Indianapolis, IN 46202,…
Zitieren
APA
Ahmed, S. S., Unland, T., Slaven, J. E., & Nitu, M. E. (2015). High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI. International Journal of Pediatrics, 2015, 1-7. https://doi.org/10.1155/2015/397372
Vancouver
Ahmed SS, Unland T, Slaven JE, Nitu ME. High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI. International Journal of Pediatrics. 2015;2015:1-7. doi:10.1155/2015/397372
BibTeX
@article{Ahmed2015,
author = {Ahmed, Sheikh Sohail and Unland, Tamara and Slaven, James E and Nitu, Mara E},
title = {High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI},
journal = {International Journal of Pediatrics},
year = {2015},
volume = {2015},
pages = {1--7},
doi = {10.1155/2015/397372}
}
EUVIMED